292618-32-7
292618-32-7
Chemical Structure
Gimatecan
Synonym(s): ST1481
- CAS No.: 292618-32-7
- Formula:C25H25N3O5
- Molecular Weight:447.48
IUPAC Name: (S,E)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-11-carbaldehyde O-(tert-butyl) oxime
InChIKey: UIVFUQKYVFCEKJ-OPTOVBNMSA-N
SMILES: CC(C)(C)O/N=C/C1=C2C(C(N3C2)=CC([C@@]4(O)CC)=C(COC4=O)C3=O)=NC5=CC=CC=C15
Biological Activity: Gimatecan (ST1481) is a potent topoisomerase I inhibitor. Gimatecan is an orally bioavailable camptothecin analogue with antitumor activity[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Gimatecan | 99.28% | Gimatecan (ST1481) is a potent topoisomerase I inhibitor. Gimatecan is an orally bioavailable camptothecin analogue with antitumor activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Gimatecan-d5 | Gimatecan-d5 (ST1481-d5) is the deuterated-labeled Gimatecan (HY-B0063). Gimatecan (ST1481) is a potent topoisomerase I inhibitor. Gimatecan is an orally bioavailable camptothecin analogue with antitumor activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
